CMN 572 Final Exam Review Questions & Answers 2026/2027 | 239 Questions | STIs, Women’s Health, Contraception, Hypertension & Menopause

This comprehensive CMN 572 Final Exam Review 2026/2027 contains 239 review questions and answers across 54 pages, with illustrations included in the study material. It provides an extensive final-exam review of sexually transmitted infections, cervical cancer and HPV, pelvic inflammatory disease, vaginal disorders, contraception, reproductive health, adult and pediatric hypertension, menopause and osteoporosis. The document emphasizes clinical presentation, risk factors, diagnostic testing, screening, treatment, medication selection, contraindications, patient counseling and follow-up, making it particularly useful for advanced nursing and primary care examination preparation. The opening portion provides detailed coverage of chlamydia, gonorrhea and syphilis. Chlamydia content includes transmission, incubation, risk factors, diagnostic testing, pregnancy and pediatric considerations, partner management, screening and complications such as PID, salpingitis, endometritis and Fitz-Hugh-Curtis syndrome. Gonorrhea review similarly addresses diagnostic methods, treatment regimens presented in the document, pregnancy, partner management, reinfection and complications. The syphilis section differentiates primary, secondary, latent, tertiary, neurosyphilis and congenital syphilis, reviewing chancres, serologic testing, VDRL/RPR, FTA-ABS, treatment and follow-up. The document then develops a substantial review of HPV, cervical dysplasia and cervical cancer screening. Students study low- and high-risk HPV, genital warts, HPV vaccination, transmission prevention and treatment approaches. Cervical cytology material covers conventional and liquid-preparation Pap tests, the transformation zone, the Bethesda system, ASC-US, ASC-H, LSIL, HSIL, AGC, ACIS, CIN 1, CIN 2, CIN 3 and carcinoma in situ. It also provides course-specific management pathways for abnormal results, including repeat testing, HPV co-testing, colposcopy and LEEP, alongside cervical screening recommendations for different age groups. Another high-yield component addresses PID, HSV-2 and common vaginal infections. PID content includes its ascending and polymicrobial nature, risk factors, minimum diagnostic criteria, treatment, hospitalization criteria and complications such as ectopic pregnancy, infertility and chronic pelvic pain. The HSV section distinguishes primary infection, recurrence and asymptomatic infection while reviewing viral culture, serology, PCR, antiviral treatment, suppressive therapy, asymptomatic shedding and pregnancy considerations. Bacterial vaginosis and trichomoniasis are covered through characteristic discharge, vaginal pH, clue cells, wet preparation, Gram stain, treatment, partner considerations and reinfection. A large section is devoted to contraception and contraceptive counseling. Students review combined oral contraceptives, extended-cycle COCs, NuvaRing, Ortho Evra, progestin-only contraception, Depo-Provera, Mirena, Kyleena, Skyla, Liletta, Nexplanon and the copper Paragard IUD. Barrier and permanent methods include male and female condoms, diaphragms, vaginal sponges, FemCap, spermicides, vasectomy and female sterilization. The resource also covers emergency contraception, lactational amenorrhea and natural family planning. Clinical counseling topics include ACHES warning signs, contraindications, adverse effects, breakthrough bleeding, Sunday start, quick start, backup contraception and follow-up schedules. The final pages broaden the review into adult and pediatric hypertension, menopause and osteoporosis. Blood-pressure content includes adult normal, elevated, Stage 1 and Stage 2 categories as presented in the document, pediatric screening and hypertension, and pharmacologic classes such as thiazide diuretics, ACE inhibitors, ARBs, beta blockers, calcium-channel blockers and alpha blockers. The menopause section covers amenorrhea, factors affecting age at menopause, AMH/MIS, vasomotor symptom management and vulvovaginal atrophy. Osteoporosis review includes bone densitometry/DXA and the FRAX risk-assessment tool. Relevant students: This document is particularly relevant to CMN 572 students, Family Nurse Practitioner students, nurse practitioner candidates, advanced practice nursing students, graduate nursing students, women’s health students, primary care students, reproductive and sexual health learners, clinical pharmacology students and healthcare professionals reviewing comprehensive primary care concepts. Because the uploaded document identifies the course as CMN 572 but does not state a university or college, the institution is accurately listed as University Not Specified rather than assigning an unsupported university name. Keywords: CMN 572 final exam, CMN 572 final exam review, CMN 572 questions and answers, CMN , CMN 572 study guide, CMN 572 exam preparation, nurse practitioner final exam, FNP exam questions, advanced practice nursing, primary care exam review, women’s health exam, sexually transmitted infections, STI exam questions, chlamydia, gonorrhea, syphilis, HPV, genital herpes, HSV 2, pelvic inflammatory disease, PID, bacterial vaginosis, trichomoniasis, cervical cancer screening, Pap smear, cervical cytology, ASC-US, ASC-H, LSIL, HSIL, CIN, colposcopy, contraception questions, combined oral contraceptives, progestin only contraception, Depo Provera, Nexplanon, Mirena, Kyleena, Paragard, emergency contraception, ACHES warning signs, adult hypertension, pediatric hypertension, antihypertensive medications, menopause, osteoporosis, DXA scan, FRAX tool, reproductive health, clinical pharmacology, graduate nursing exam